Francis Mussai
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Immune cells in cancer 7
- Biotechnology top 2%
- Cancer Research and Treatments 7
- Hematology top 5%
- Acute Myeloid Leukemia Research 6
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Oncology top 5%
- CAR-T cell therapy research 6
-
- Neuroblastoma Research and Treatments 7
-
- Virus-based gene therapy research 4
- Co-authors
- Carmela De SantoSarah BoothLivingstone FultangVincenzo CerundoloAmrana QureshiRosanna M. McEwen-SmithIssa Abu‐DayyehParesh Vyas
- Cited by
- ImmunologyBiotechnologyHematology
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Francis Mussai
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 83
- Immunology 591
- Biotechnology 238
- Hematology 296
- Cancer Research 284
- Oncology 510
Countries citing papers authored by Francis Mussai
This map shows the geographic impact of Francis Mussai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Mussai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Mussai more than expected).
Fields of papers citing papers by Francis Mussai
This network shows the impact of papers produced by Francis Mussai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Mussai. The network helps show where Francis Mussai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francis Mussai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 28 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 17 | |
| 10 | 2019 | 2 | |
| 11 | 2018 | 43 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 49 | |
| 14 | 2016 | 11 | |
| 15 | 2015 | 84 | |
| 16 | 2015 | 2 | |
| 17 | 2012 | 27 | |
| 18 | 2010 | 61 | |
| 19 | 2008 | 6 | |
| 20 | 2007 | 1 |
About Francis Mussai
Francis Mussai is a scholar working on Biotechnology, Hematology and Immunology, having authored 40 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Research and Treatments (7 papers), Neuroblastoma Research and Treatments (7 papers), Immune Cell Function and Interaction (7 papers), Immune cells in cancer (7 papers), Acute Myeloid Leukemia Research (6 papers), CAR-T cell therapy research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Immunology (591 citations), Biotechnology (238 citations) and Hematology (296 citations). Francis Mussai has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Carmela De Santo, Sarah Booth, Livingstone Fultang, Vincenzo Cerundolo, Amrana Qureshi, Rosanna M. McEwen-Smith, Issa Abu‐Dayyeh, Paresh Vyas, Francesco Dazzi and Lynn Quek. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.